Pediatric, Geriatric, and Special Population Pharmacology

This session focuses on the unique pharmacological and toxicological considerations in pediatric, geriatric, and other special populations, emphasizing how biological differences influence drug efficacy, safety, and dosing strategies. The session will explore age-related physiological changes, including variations in absorption, distribution, metabolism, and excretion, as well as the impact of comorbidities, polypharmacy, and organ dysfunction on drug response. In pediatrics, discussions will cover developmental pharmacokinetics, growth-dependent metabolism, and the challenges of establishing safe and effective dosing in neonates, infants, and adolescents. In geriatrics, the session will address altered pharmacodynamics, increased susceptibility to adverse drug reactions, and strategies to minimize polypharmacy risks while optimizing therapeutic outcomes. Special populations such as pregnant or lactating individuals, patients with renal or hepatic impairment, and those with rare genetic conditions will also be highlighted, with emphasis on biologically informed dose individualization and therapeutic monitoring. Clinical case studies and real-world examples will illustrate how tailored pharmacological strategies can reduce toxicity, enhance efficacy, and improve patient safety. Emerging tools such as physiologically based pharmacokinetic modeling, pharmacogenomic testing, and biomarker-guided therapy will be discussed for their role in predicting drug response and adverse events in these populations. Ethical, regulatory, and practical considerations in conducting clinical research and therapy optimization for vulnerable groups will also be addressed. By integrating biological, clinical, and regulatory perspectives, this session aims to provide participants with a comprehensive understanding of how to safely and effectively apply pharmacological principles in diverse patient populations, ultimately enhancing individualized care and therapeutic outcomes.

    Related Conference of Pediatric, Geriatric, and Special Population Pharmacology

    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    June 08-09, 2026

    20th World Drug Delivery Summit

    London, UK
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Pediatric, Geriatric, and Special Population Pharmacology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in